Press Releases

Hong Kong International Airport (HKIA) and Brussels Airport announced the launch of an airport-to-airport (A2A) pharma corridor, offering services catering to the specific needs of pharmaceutical shipments. Spearheaded by the two airports and in collaboration with...

Omya, a leading manufacturer of mineral ingredients, has developed two new tablet concepts which were introduced at Health ingredients Europe 2018. Omya sprint is an orally disintegrating tablet (ODT) based on the excipient Omyapharm® and vitamin...

PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively. PAREXEL Biotech builds on the...

Medigene AG reported that an additional European Patent was granted for its dendritic cell (DC) vaccine platform. The European Patent EP2918673 covers an isolated mature dendritic cell or an isolated population of mature dendritic cells obtainable...

Aptar Pharma is pleased to announce the co-organization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, which will connect pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal, May 7-10,...

The US FDA has approved Portola Pharmaceuticals’ Prior Approval Supplement (PAS) for the manufacturing process of second generation Andexxa . Andexxa received both U.S. Orphan Drug and FDA Breakthrough Therapy designations and was initially approved on...

Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and...